Birlasoft, Mamaearth, Rossari Biotech, 3 other stocks brokerages are bullish on; check out their targets
These recommendations from the analysts have the potential for gains ranging from 20 per cent to 45 per cent.
With the Nifty50 having retreated more than a percentage point just after scaling a fresh lifetime high, investors are once again on the lookout for stocks to add to their portfolios. Domestic brokerages such as Nuvama, Anand Rathi and Motilal Oswal Financial Services have handpicked a few stocks from a long-term perspective. Their targets imply an upside of as much as 45 per cent in six stocks including Birlasoft, Rossari Biotech and Star Health. Check out the full list here:
(Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.)
Buy | Birlasoft Shares | Anand Rathi
Birlasoft share price target: Anand Rathi has recommended buying the Birlasoft stock for a target of Rs 810 per share revised from Rs 870. They expected that FY24-26 revenue would CAGR of 9.5 per cent, EBITDA CAGR of 16.9 per cent and PAT CAGR of per cent. The brokerage firm asserted that healthcare fell sharply and is likely to recover only in H2.
Buy | Rossari Biotech Shares | Nuvama
Rossari Biotech share price target: Nuvama has a ‘buy’ call on the Rossari Biotech stock with a target of Rs 949. “The company has expanded its footprint in agrochemicals, oil and gas, chemicals, silicon oils, and most importantly in institutional cleaning (through its subsidiary Buzil Rossari Pvt), which will aid growth,” it said. They expected that expect the healthy growth in HPPC (Home-Personal Care and Performance Chemicals) to be sustained over the next couple of years.
Buy | Star Health Shares | Motilal Oswal
Star Health share price target: MOFSL has recommended buying the Star Health stock with a target of Rs 730 with a potential upside of 28 per cent. They expected that the prices of senior citizen health insurance products and the Young Star insurance product would increase by 15-20 per cent in 1QFY25. These products account for 10 per cent of the total premium. “We believe that Star Health can deliver long-term growth with the investments made in profitable channels and products,” MOFSL said.
Buy | Can Fin Homes Shares | Sharekhan
Sharekhan has maintained a ‘buy’ call on the Can Fin Homes shares with a target of Rs 960. According to the brokerage, the stock will rise to 25 per cent.
Buy | Mamaearth Shares | Emkay
Emkay has maintained a ‘buy’ call on the Honasa Consumer stock. The brokerage has kept a target of Rs 500 with an upside potential up to 20 per cent.
Buy | IndusInd Bank Shares| KRChoksey
IndusInd Bank share price target: KRChoksey has maintained a ‘buy’ call on the IndusInd Bank stock with a revised target of Rs 1,850. According to the brokerage, the stock has a return potential of up to 22 per cent. “We expect NII, PPOP and PAT to grow at a CAGR of 16.2 per cent, 17.1 per cent, and 18.4 per cent, respectively over FY24-26E,” it said.